Annual report pursuant to Section 13 and 15(d)

Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Gain on the Sale of the Business and Net Proceeds

v3.24.3
Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Gain on the Sale of the Business and Net Proceeds - Clinical Labs Business [Member]
$ in Thousands
12 Months Ended
Jul. 31, 2024
USD ($)
Schedule of Gain on the Sale of the Business and Net Proceeds [Line Items]  
Gross consideration from the sale of the Clinical Labs business $ 113,250
Closing and transaction costs (9,941)
Consideration from sale of the Clinical Labs business – net 103,309
Net book value of assets sold or abandoned (19,818)
Gain on sale of the Clinical Labs business before income taxes 83,491
Income tax expense (860)
Gain on the sale of the Clinical Labs business after income taxes 82,631
Net cash proceeds from sale:  
Cash paid at closing, net of closing costs paid at closing 106,740
Proceeds due on sale of assets, cash held in escrow (5,000)
Net cash proceeds from sale $ 101,740